Anhui Deepblue Medical Technology Co., Ltd. (hereinafter referred to as "Deepblue Medical") is a new type of biotechnology enterprise specializing in the research and development, production and sales of gynecological testing, diagnostic reagents for family planning and biological raw materials. The main scope includes Class I and Class II , Production and sales of three types of medical devices and in-vitro diagnostic reagents; self-support and agency for the import and export business of various commodities and technologies (except those prohibited or restricted by national laws and regulations); production and sales of disinfection products; research and development of biomedical products; biomedical technology Consulting, technology transfer, technology promotion services; medical consulting services; medical investment. Deepblue Medical adheres to the innovation and development route, core products are patented by independent research and development, the company pays attention to intellectual property cultivation, carries out industry-university-research cooperation, changes the traditional industry single market development model with technological innovation, introduces the big data platform to the company, and develops e-commerce. Sales, develop a new business model, belong to the typical Internet + production enterprises. Enterprises adhere to innovation-driven, focus on cultivating and expanding strategic emerging industries, transforming and upgrading traditional industries, carrying out technological innovation, management innovation and business model innovation, cultivating new growth points, and forming new competitive advantages. The company has two invention patents, four utility models, and seven computer software copyrights.   At present, Deepblue Medical has applied for multi-directional trademark brands, mainly: DEEPBLUE, DeepBlue, Binggang, Bingzhining, Deepblue Kuaishou, Xinxiaoan, among which, "DEEPBLUE" has obtained the Madrid International Trademark Registration Certificate.